SIE

209.45

+2.95%↑

AIR.FR

165.7

+2.82%↑

ENR.DE

147.6

+3.91%↑

RHM

1,475.5

-1.83%↓

HO

239.6

-0.13%↓

SIE

209.45

+2.95%↑

AIR.FR

165.7

+2.82%↑

ENR.DE

147.6

+3.91%↑

RHM

1,475.5

-1.83%↓

HO

239.6

-0.13%↓

SIE

209.45

+2.95%↑

AIR.FR

165.7

+2.82%↑

ENR.DE

147.6

+3.91%↑

RHM

1,475.5

-1.83%↓

HO

239.6

-0.13%↓

SIE

209.45

+2.95%↑

AIR.FR

165.7

+2.82%↑

ENR.DE

147.6

+3.91%↑

RHM

1,475.5

-1.83%↓

HO

239.6

-0.13%↓

SIE

209.45

+2.95%↑

AIR.FR

165.7

+2.82%↑

ENR.DE

147.6

+3.91%↑

RHM

1,475.5

-1.83%↓

HO

239.6

-0.13%↓

Search

SPIE SA.

Gesloten

SectorIndustrieën

44.5 2.16

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

42.84

Max

45.44

Belangrijke statistieken

By Trading Economics

Inkomsten

203M

190M

Verkoop

350M

5.4B

K/W

Sectorgemiddelde

44.519

61.065

Dividendrendement

2.34

Winstmarge

3.512

Werknemers

54,673

EBITDA

317M

629M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+24.6% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

2.34%

2.23%

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-987M

7.9B

Vorige openingsprijs

42.34

Vorige sluitingsprijs

44.5

Nieuwssentiment

By Acuity

70%

30%

379 / 406 Rangschikking in Industrials

Technische score

By Trading Central

Vertrouwen

Weak Bullish Evidence

SPIE SA. Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

23 mrt 2026, 23:47 UTC

Acquisities, Fusies, Overnames

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23 mrt 2026, 22:55 UTC

Acquisities, Fusies, Overnames

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23 mrt 2026, 21:51 UTC

Acquisities, Fusies, Overnames

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23 mrt 2026, 23:59 UTC

Marktinformatie

Global Equities Roundup: Market Talk

23 mrt 2026, 23:59 UTC

Marktinformatie

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23 mrt 2026, 23:50 UTC

Marktinformatie

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23 mrt 2026, 23:37 UTC

Marktinformatie

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23 mrt 2026, 22:42 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Global Equities Roundup: Market Talk

23 mrt 2026, 22:42 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23 mrt 2026, 22:40 UTC

Acquisities, Fusies, Overnames

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23 mrt 2026, 22:23 UTC

Marktinformatie

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23 mrt 2026, 22:22 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23 mrt 2026, 22:21 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23 mrt 2026, 22:21 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23 mrt 2026, 22:20 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23 mrt 2026, 22:20 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23 mrt 2026, 22:19 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23 mrt 2026, 22:19 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23 mrt 2026, 22:18 UTC

Acquisities, Fusies, Overnames

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23 mrt 2026, 22:15 UTC

Acquisities, Fusies, Overnames

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23 mrt 2026, 22:08 UTC

Marktinformatie

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23 mrt 2026, 21:42 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

23 mrt 2026, 21:42 UTC

Marktinformatie

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23 mrt 2026, 21:32 UTC

Winsten

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23 mrt 2026, 21:32 UTC

Winsten

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23 mrt 2026, 21:32 UTC

Winsten

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23 mrt 2026, 21:10 UTC

Belangrijke Nieuwsgebeurtenissen

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23 mrt 2026, 20:50 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

23 mrt 2026, 20:50 UTC

Marktinformatie

Health Care Roundup: Market Talk

23 mrt 2026, 20:50 UTC

Marktinformatie
Winsten
Belangrijke Nieuwsgebeurtenissen

Basic Materials Roundup: Market Talk

Peer Vergelijking

Prijswijziging

SPIE SA. Prognose

Koersdoel

By TipRanks

24.6% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 54 EUR  24.6%

Hoogste 57 EUR

Laagste 51 EUR

Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor SPIE SA. - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

2 ratings

1

Buy

1

Hold

0

Sell

Technische score

By Trading Central

43.14 / 43.96Steun & Weerstand

Korte Termijn

Weak Bullish Evidence

Gemiddeld Termijn

Bullish Evidence

Lange Termijn

Bullish Evidence

Sentiment

By Acuity

379 / 406 Rangschikking in Industrieën

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over SPIE SA.

SPIE SA provides multi-technical services in the areas of energy and communications in France, Germany, the Netherlands, and internationally. The company operates through four segments: France; Germany and Central Europe; North-Western Europe; and Oil & Gas and Nuclear. It provides building modelling and design services; IT maintenance and managed services; information and communications technology engineering and consulting services; technical facility management, energy-efficiency, and technical services for the transmission and distribution of energy for industrial clients, as well as in the areas of electrical and security, HVAC, and information and communications technology; and electrical, mechanical, and HVAC engineering services. The company also offers building information modelling, building management systems, augmented reality, IoT and data management, and smart maintenance services; oil and gas services; construction, renovation, and maintenance services for bridges, locks, and pumping stations; maintenance and innovative solutions for traffic infrastructure; and fixed and mobile digital telecom networks, as well as technical building management, communications and networks, and tech FM services; engineering, construction, maintenance, and optimization services for industrial processes; energy recovery and sustainable management services to technical facilities; and energy transmission networks, medium-voltage facilities, distribution networks, busbar systems, and wind and solar power farms. In addition, it engages in the analysis of site conditions; planning, installation, and commissioning of technology; mechanical and industrial robotic solutions; and provision of electric solutions comprising lighting, street lighting, safety and security, prefabrication, and signage solutions. SPIE SA was founded in 1900 and is headquartered in Cergy-Pontoise, France.
help-icon Live chat